C20ORF202 antibody (AA 51-122) (Biotin)

Catalog No. ABIN1699894

Product Details anti-C20ORF202 Antibody (Biotin)

Target: C20ORF202 (Chromosome 20 Open Reading Frame 202 (C20ORF202))

Binding Specificity: AA 51-122

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This C20ORF202 antibody is conjugated to Biotin

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Predicted Reactivity: Human

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C20orf202

Isotype: IgG

Application Details

Application Notes: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C for 12 months.

Expiry Date: 12 months

Target Details for C20ORF202

Target: C20ORF202 (Chromosome 20 Open Reading Frame 202 (C20ORF202))

Alternative Name: C20orf202 (C20ORF202 Products)

Synonyms: chromosome 20 open reading frame 202 antibody, C20orf202 antibody

Background:

Synonyms: C20orf202, CT202_HUMAN, Uncharacterized protein C20orf202.

Background: C20orf202 is a 122 amino acid protein that is pending further characterization. The gene encoding C20orf202 maps to human chromosome 20. Comprising approximately 2 % of the human genome, chromosome 20 contains nearly 63 million bases that encode over 600 genes, some of which are associated with Creutzfeldt-Jakob disease, amyotrophic lateral sclerosis, spinal muscular atrophy, ring chromosome 20 epilepsy syndrome and Alagille syndrome. Additionally, chromosome 20 contains a region with numerous genes which are thought to be important for seminal production and may be potential targets for male contraception.